 Leap Therapeutics Inc. LPTX , Financial lived up to its name when it scored a big jump in stock price following its presentation at the recent European Society for Medical Oncology meeting. The Cambridge, Massachusetts-based microcap saw its shares climb 23 to 2.3650 after it reported new data from the study of its drug for treating gastroesophageal junction cancer. 